Open Access

The diagnostic role of diffusion-weighted magnetic resonance imaging in hypopharyngeal carcinoma

  • Authors:
    • Si‑Cong Zhang
    • Shui‑Hong Zhou
    • De‑Sheng Shang
    • Yang‑Yang Bao
    • Ling‑Xiang Ruan
    • Ting‑Ting Wu
  • View Affiliations

  • Published online on: February 14, 2018     https://doi.org/10.3892/ol.2018.8053
  • Pages: 5533-5544
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to assess the role of diffusion-weighted magnetic resonance imaging (DWI) and apparent diffusion coefficient (ADC) values in hypopharyngeal carcinoma. A total of 40 hypopharyngeal carcinoma tissues and 15 benign lesion tissues were retrospectively analyzed. DWI, and T1‑ and T2‑weighted magnetic resonance imaging (MRI) was performed. The sensitivity, specificity and accuracy of conventional MRI were 97.5, 66.7, and 89.1%, respectively. The mean ADC value [diffusion sensitive factor (b)=1,000x sec/mm2) for hypopharyngeal carcinomas was (1.0285±0.0328)x10‑3 mm2/sec, which was significantly lower than the mean ADC value for benign lesions [(1.5333±0.1061)x10‑3 mm2/sec; P<0.001]. Receiver operating characteristic (ROC) curve analysis revealed that the area under the curve (AUC) was 0.921 while the optimal threshold for the cut‑off point of the ADC was 1.075x10‑3 mm2/sec. The mean ADC value of the metastatic nodes was (0.9184±0.0538)x10‑3 mm2/sec, lower than the mean value for the benign nodes [(1.2538±0.1145)x10‑3 mm2/sec; P=0.005]. Two groups were created according to the mean of the ADC value of hypopharyngeal carcinomas [≤(1.0285±0.0328)x10‑3 mm2/sec vs. >(1.0285±0.0328)x10‑3 mm2/sec]. The 2‑year survival rates of the two groups were 55.6 and 100.0%, respectively (P=0.024). ADC values may aid in distinguishing hypopharyngeal carcinomas from benign lesions and differentiating metastatic lymph nodes of hypopharyngeal squamous cell carcinomas from reactive cervical lymph nodes. In conclusion, mean ADC values may be useful prognostic factors in univariate analysis of hypopharyngeal carcinoma.

Introduction

Hypopharyngeal carcinoma has one of the poorest prognoses of all head and neck carcinomas as it is frequently diagnosed at an advanced stage and exhibits aggressive and distant metastasis (1). Although there have been significant advancements in surgical techniques and chemoradiotherapy recently, the prognosis of hypopharyngeal carcinoma remains unsatisfactory (2).

At present, the most common diagnostic tools include different types of laryngoscopy, computed tomography (CT), and routine magnetic resonance imaging (MRI). CT may reveal the extent of infiltration of hypopharyngeal carcinoma, but it also has certain limitations, including over estimation of invasion of the vocal cords, underestimation of invasion of the upper esophagus, difficulty in displaying mild invasion of thyroid cartilage, and uncertainty with regard to the normal size of the cervical lymph nodes and whether they are subject to metastasis. Routine MRI has high resolution in soft tissue, enabling it to accurately determine the infiltration extent of tumors; however, it remains a challenge to diagnose small lesions or micrometastatic nodes (3). Positron emission tomography (PET) and PET/CT may supply functional information and differentiate malignant tumors from benign lesions; however, they are expensive with low availability and are limited by relatively low spatial resolution and risk of radiation exposure (3).

Recently, diffusion-weighted MRI (DWI) has emerged as a relatively novel functional imaging tool that records the molecular motion of protons corresponding to Brownian motion within living tissue (4). The extent of molecular diffusion may be estimated and quantified in terms of the apparent diffusion coefficient (ADC) (5). DWI is widely used in clinical practice to differentiate benign masses from malignant tumors, to diagnose lymph node metastasis, to detect recurrent lesions following radiotherapy/chemotherapy, and to predict the effect of treatment using DWI and ADC values. DWI is able to detect changes in tumor size and shape prior to them becoming visible to the naked eye, and the ADC value is affected by cell size, density and integrity (6).

Initially, DWI was primarily used in neurology to identify intracranial lesions. However, the complex anatomical structure and functions occurring in the head and neck, including respiration, swallowing and phonation, limit the use of DWI in these regions. Nonetheless, with the advances in MRI technical performance and MRI machinery, the application of DWI to head and neck oncology is increasing (7,8). Head and neck cancer occurs at multiple sites, including the oral cavity, oropharynx and larynx (9,10). Recently, Driessen et al (10) used single-shot spin-echo echo-planar DWI of 1.5T MRI to investigate the association between histological characteristics of laryngeal and hypopharyngeal squamous cell carcinoma and ADC values (10). However, to the best of our knowledge, few previous studies have investigated the role of DWI at a single site in the head and neck regions. To the best of our knowledge, our previous study was the first to successfully use DWI and 3.0-T MRI to differentiate preoperative laryngeal carcinomas from precursor lesions (11), and there have been no previous studies regarding the use of ADC values and single-shotecho-planar imaging sequence (EPI) of 3.0-T MRI alone in hypopharyngeal carcinoma.

The aim of the present study was to assess the role of DWI and ADC values in hypopharyngeal carcinoma in order to determine: i) Whether ADC has diagnostic value in discriminating carcinomas from benign lesions, or discriminating metastatic lymph nodes from reactive cervical lymph nodes; and ii) whether ADC values are associated with the prognosis of hypopharyngeal carcinomas.

Materials and methods

Patients

The present study was approved by the Institutional Review Board of the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China (IRB no. 2015428), and written informed consent was obtained from all enrolled patients.

Between June 2012 and July 2015, patients with hypopharyngeal lesions who had undergone preoperative laryngostroboscopy (Endo-stroboscope L; Atmos Medizin Technik GmbH & Co. KG, Lenzkirch, Germany) and DWI were considered for inclusion in the present study. The inclusion criteria were as follows: i) Suspicious lesions in the hypopharynx on laryngostroboscopy; ii) 3.0-T MRI (including DWI, b=0 and 1,000 sec/mm2) prior to treatment; iii) surgery, concurrent chemo-radiotherapy (CCR) and pathological confirmation of diagnoses (including frozen sections and routine pathological results); and iv) availability of complete clinical data. Exclusion criteria were as follows: i) Incomplete clinical data; ii) 3.0-T MR without DWI prior to treatment; iii) undetermined Tumor-Node-Metastasis (TNM) stage of hypopharyngeal carcinoma (11) or recurrent hypopharyngeal carcinoma requiring a second surgery.

Consequently, 63 patients (62 males and 1 female) were included. The mean age of was 55.3 years (range, 30–81 years). Of these patients, 4 were excluded owing to susceptibility artifacts (due to linear blurring, geometric distortion or imaging distortion) that compromised image quality. A total of 4 patients, who waived any treatment, were also excluded. In the remaining 55 patients, pathological results revealed 40 cases of hypopharyngeal carcinoma (Table I) and 15 benign lesions. In cases where a suspicious mass at the primary site or a neck mass was observed on physical examination or CT/MRI, a biopsy or needle biopsy was performed. The tumor volume (TV) of samples was calculated as follows: TV=XxYxZ/2 (X, greatest length; Y, greatest width and Z, greatest depth of tumor samples). Patients were followed up every 1 month over the first year, every 3 months over the second year, every 6 months over the next 3 years and annually thereafter. The last follow-up date was March 2015.

Table I.

The clinicopathological characteristics of 40 patients with hypopharyngeal carcinoma.

Table I.

The clinicopathological characteristics of 40 patients with hypopharyngeal carcinoma.

PatientSexAge, yearsSiteTNM stageTreatmentHRMETFollow-up
  1M67Right PST3N0M0 ND+surgery+preservation of LFMNoNo9 months, NED
  2M45Right PST4N2cM0PRT(50 Gy)+ND+surgery+preservation of LFM3 months after surgeryNo9 months, mortality due to hemorrhea
  3F42Left PS, involving the upper esophagusT4N0M0 ND+surgery+preservation of LFM-P9 months after surgeryLung metastasis 9 months after surgery10 months, AWD
  4M57Left PST3N2cM0 ND+surgery+preservation of LF+postoperative CCRMNoNo16 months, NED
  5M80Left PST3N0M0 ND+surgery+preservation of LF+postoperative CCRM-P10 months after surgeryPulmonary metastasis, 10 months after surgery10 months, AWD
  6M71Left PST3N1M0 ND+surgery+preservation of LF+postoperative CCRMNoPulmonary metastasis after surgery 13 months after surgery13 months, AWD
  7M59Left PST4N2bM0 ND+surgery+preservation of LF+postoperative CCRPNoNo15 months, NED
  8M78 RetropharyngealT2N0M0 ND+surgery+preservation of LFWNoNo13 months, NED
  9M61PRT3N1M0 ND+surgery+TFO+postoperative CCRMNoNo14 months, NED
10M58Right PST4N2aM0ND+surgery+total laryngectomy+ postoperative CCRW-MNoNo15 months, NED
11M66Left PST4aN2aM0ND+surgery+TFOMNoNo6 months until mortality
12M70 RetropharyngealT4N0M0Postoperative CCRMNoNo15 months, NED
13M60Right PST4N2aM0 ND+surgery+preservation of LF+postoperative CCRM-PNoNo13 months until mortality
14M74Right PST4N1M0 ND+surgery+preservation of LF+postoperative CCRM-PNoNo18 months, NED
15M48PRT4aN2CM0 ND+surgery+TFO+postoperative CCRM-PNoNo19 months, NED
16M75Left PST4bN2M0Postoperative CCRW-MNoNo5 months until mortality
17M65Light PST3N0M0 ND+surgery+preservation of LF+postoperative CCRPNoNo19 months, NED
18M63Light PST4aN1M0 ND+surgery+preservation of LF+postoperative CCRMNoNo19 months, NED
19M70Right PST3N1M0ND+surgery+total laryngectomy+postoperative CCRMNoNo10 months, mortality due tohemorrhea
20M67PRT4N0M0 ND+surgery+TFO+postoperative CCRM-PNoNo23 months, NED
21M77Left PST3N2bM0 ND+surgery+preservation of LFMNoNo25 months, NED
22M54Right PST2N2M0 ND+surgery+preservation of LF+ postoperative CCRNANoNo27 months, NED
23M67Left PST2N1M0 ND+surgery+preservation of LF+postoperative CCRM-PNoNo26 months, NED
24M56Left PST2N2M0ND+surgery+total laryngectomyM-PNoNo15 months, mortality due to accidental injury
25M58PRT1N1M0 ND+surgery+preservation of LF+postoperative CCRW-MNoNo27 months, NED
26M59Right PST2N2M0 ND+surgery+TFO+postoperative CCRM-PNoNo28 months, NED
27M50Left PST2N2M1Postoperative CCRMNANANA
28M57Left PST4N1M0 ND+surgery+preservation of LF+postoperative CCRMNoNo33 months, NED
29M57PRT4N2cM0 ND+surgery+TFO+postoperative CCRMNoNo9 months, NED
30M45Right PST2N1M0 ND+surgery+preservation of LF+postoperative CCRPNoNo8 months, NED
31M55PRT4N1M0 ND+surgery+TFO+postoperative CCRM-PNoNo8 months, NED
32M68 RetropharyngealT4N1M0 ND+surgery+preservation of LF+postoperative chemotherapyM-PNoMediastinal lymph node 8 months metastasis after surgery7 months, AWD
33M50 RetropharyngealT4N0M0 ND+surgery+preservation of LF+postoperative CCRMNoNo5 months, NED
34M69Right PST2N0M0 ND+surgery+preservation of LFMNoNo6 months, NED
35M53 RetropharyngealT4N0M0ND+surgery+TFOW-MNoNo3 months, NED, continues CCR treatment
36M81Right PST2N0M0 ND+surgery+preservation of LFMNoNo3 months, NED, in the CCR
37M60Left PST4N1M0ND+surgery+TFOW-MNoNo2 months, NED, in the CCR
38M68Right PST3N2M0 ND+surgery+preservation of LFMNoNo2 months, NED, in the CCR
39M62Left PST3N2M0 ND+surgery+preservation of LFM-PNoNo3 months, NED, in the CCR
40M62Left PST4aN2M0 ND+surgery+preservation of LFW-MNoNo1 months, NED, in the CCR

[i] TNM, Tumor-Node-Metastasis; H, histopathological grade; R, recurrence; MET, metastasis; PS, pyriform sinus; PR, postcricoid region; ND, neck dissection; LF, laryngeal function; PRT, preoperative radiotherapy; TFO, tracheostomy fistula operation; W, well differentiated; M, moderately differentiated; P, poorly differentiated; NED, no evidence of disease; AWD, alive with disease; NA, not available due to lack of patient participation.

MRI protocol

All MRI examinations were performed using a 3.0-T MRI scanner (Philips Achieva® 3.0T; Royal Philips Electronics, Amsterdam, Netherlands) with a 16-channel head and neck coil. Conventional MRI included an axial T1-weighted turbo spin echo (TSE) sequence with the following parameters (11): Slice thickness, 4 mm; 24 slices; intersection gap, 1 mm; repetition time/echo time (TR/TE), 450 ms/10 ms; matrix, 320×224; field of view (FOV), 240×180 mm; and an axial T2-weighted TSE sequence (slice thickness, 4 mm; 24 slices; intersection gap, 1 mm; TR/TE, 400 ms/10 ms; matrix, 320×224; FOV, 240×180 mm). The coronal T2-weighted TSE sequence included the following parameters: Slice thickness, 4 mm; 24 slices; intersection gap, 1 mm; TR/TE, 400 ms/10 ms; matrix 320×224; FOV, 240×220 mm; and two signals were acquired, covering the larynx. Following gadolinium injection, T1-weighted fat-saturated sequences were performed in the axial plane (using identical parameters to pre-contrast medium administration) and in the coronal plane (24 slices; slice thickness, 4 mm; intersection gap, 1 mm; TR/TE, 540 ms/9.2 ms; matrix, 320×224; FOV, 240×220 mm; and two signals were acquired using fat suppression).

DWI was performed with a single-shot EPI-DWI). The parameters were as follows: TR/TE, 8,000 ms/60 ms; FOV, 240×240 mm; matrix, 124×124; 24 slices; slice thickness, 4 mm; and b=0 or 1,000 sec/mm2). ADC maps were generated using Extended MR Workspace (EWS). In order to minimize susceptibility artifacts, the patients were encouraged not to swallow, speak or cough during imaging. In addition, thin slices were obtained, meticulous shimming was applied and sight fixation (to steady the patient's head) were used.

Image analysis

The imaging data were reviewed by two radiologists from the Department of Radiology (the First Affiliated Hospital, Zhejiang University, Hangzhou, P.R. China) with specific experience in head and neck imaging, but with no knowledge of the primary lesion. They reached an agreed opinion prior to reviewing the pathology results. The lesion contour, size and internal architecture were documented. An ADC map was generated by DWI with EWS and the ADC value was measured.

All hypopharyngeal lesions were characterized based on the signal intensity in T1- and T2-weighted MRIs and enhancement characteristics. DW-MRI at a native b-value of 1,000 sec/mm2 (b-1,000 images) and the corresponding ADC maps were matched to and evaluated with the morphological images as previously described (11). A hyperintense signal on the native b-1,000 image compared with the surrounding tissue with a corresponding low signal intensity in the matching ADC map was considered positive for a tumor. A high signal intensity on the b-1,000 image with a corresponding high signal intensity on the matching ADC map was considered to represent T2 shine-through and therefore, the absence of a tumor. The absence of hyper intensity on the b-1,000 image was also considered negative for a tumor. The region of interest (ROI) on single slice was determined by a single radiologist (Department of Radiology (the First Affiliated Hospital, Zhejiang University, Hangzhou, P.R. China) with 20 years of experience. The ROI was determined as previously described (12). In brief, the ROIs were placed on the axial ADC 1,000 maps following referral to contrast-enhanced T1-weighted images obtained in 3 orthogonal planes. The investigator (Department of Radiology (the First Affiliated Hospital, Zhejiang University, Hangzhou, P.R. China) had no knowledge of the final pathological or clinical results when he interpreted the images. The ROIs were drawn on the largest or the highest conspicuity of the lesion of the ADC map. The boundary of the ROI contained the visible tumor in that section of the ADC map corresponding to T1-weighted, T2-weighted, or contrast-enhanced T1-weighted images, but any necrotic portions and normal osseous structures were avoided where possible. The ADC value in the same section was calculated three times. The mean ± standard deviation (SD) of the ADC values for the hypopharyngeal lesions and cervical lymph nodes were calculated.

Statistical analyses

Statistical analyses were performed using SPSS software 20.0 (IBM Corp., Armonk, NY, USA). P<0.05 was considered to indicate a statistically significant difference. All variables were assessed for normality by using the Kolmogorov-Smirnov test. Spearman's rank correlation was performed to evaluate the correlation between tumor size and ADC value. Differences in ADC (mean ± SD) of the hypopharyngeal lesions between patients with malignant lesions and those with benign lesions were tested using an independent samples t-test. A 95% confidence interval was used. In the univariate survival analysis, the curves for overall survival were estimated using the Kaplan-Meier method, and the log rank test was used to test differences between groups. Multivariate analysis was performed using a Cox proportional hazard test.

Receiver operating characteristic (ROC) curve analysis was used to investigate the discriminatory ability of the ADC values in differentiating hypopharyngeal carcinomas from benign lesions. The area under the ROC curve (AUC) was calculated. The ADC value that corresponded to the highest Youden index (sensitivity+specificity-1) was chosen as the optimal ADC threshold value as it optimized the sensitivity and specificity. The AUC was used as an alternative global measure of test performance.

Results

Patient clinical characteristics

The mean age of the patients with benign hypopharyngeal lesions was 56.5 years (range, 34–74 years). There were 13 males and 2 females. The main symptoms included a sensation of a foreign body in the throat and pharyngalgia. The benign hypopharyngeal lesions included 10 cases of chronic inflammation, two vascular lesions, two hypopharyngeal polyps and one cyst.

Of the 40 patients with hypopharyngeal carcinoma, 39 were male and one was female. The mean age was 61.4 years (range, 42–81 years). All 40 hypopharyngeal carcinomas were squamous cell carcinoma (SCC). A total of 29 tumors (72.5%) were located in the pyriform sinus, 8 (20.0%) were located in the posterior pharyngeal wall and 3 (7.5%) were located in the postcricoid area. A total of 36 patients (90.0%) had a history of smoking, 32 (80.0%) had a history of drinking (any alcohol consumption), and 27 (67.5%) had a history of smoking and drinking. Signs and symptoms included odynophagia (32.5%), difficulty swallowing (30.0%), sensation of a foreign body in the throat (20.0%), neck mass (10.0%) and hoarseness (2.5%). According to the International Union Against Cancer TNM classification system (2007, 7th edition), 1 patient (2.5%) exhibited stage T1N1M0 disease, 3 (7.5%) exhibited stage T2N0M0 disease, 3 (5.0%) exhibited stage T2N1M0 disease, 3 (7.5%) exhibited stage T2N2M0 disease, 3 (7.5%) exhibited stage T3N0M0 disease, 3 (7.5%) exhibited stage T3N1M0 disease, 4 (10.0%) exhibited stage T3N2M0 disease, 5 (12.5%) exhibited stage T4N0M0 disease, 6 (15.0%) exhibited stage T4N1M0 disease, 9 (22.5%) exhibited stage T4aN2M0 disease, 1 (2.5%) exhibited stage T2N2M1 disease, and one patient developed lung metastasis. With regards to clinical stage (11), 2 patients (5.0%) exhibited stage II disease, 8 (20.0%) exhibited stage III disease, and 30 (75.0%) exhibited stage IV disease (Table I). According to current classifications, 95.0% of patients were at an advanced stage of disease. A total of 3 patients received CCR, while 37 patients received surgery and neck dissection (18 ipsilateral and 19 bilateral). One of the 37 patients received preoperative CCR and 36 received postoperative CCR.

The mean longest diameter of the tumor samples was 4.7 cm and ranged between 2.0 and 10.0 cm. The mean tumor volume was 38.8 cm3 and ranged between 4.0 and 210 cm3 (Table II).

Table II.

Tumor sizes and ADC values.

Table II.

Tumor sizes and ADC values.

PatientTumordiameter, cmTumor volume, cm3ADC, 10−3 mm2/sec
  14.0×3.0×2.5015.000.89
  23.5×3.0×1.05.250.96
  33.0×3.0×1.26.751.32
  44×2.5×1.57.500.92
  53.0×3.0×2.09.001.06
  63.4×3.0×3.015.301.05
  74.0×4.0×2.520.000.88
  85.0×5.0×3.543.751.06
  97.5×4.5×233.750.92
103.0×4.0×4.024.000.70
115.0×4.5×1.516.880.80
122.0×3.5×3.512.250.97
134.0×5.0×5.050.000.45
143.0×3.0×3.013.501.05
155.0×5.0×5.568.750.98
165.0×5.0×5.062.500.80
174.0×3.0×3.018.001.41
184.0×4.0×5.040.000.97
194.0×4.0×5.544.000.96
204.0×5.5×5.560.501.00
213.0×5.5×7.057.750.89
222.0×2.0×2.04.001.14
234.0×3.0×3.018.001.16
243.0×3.0×3.013.500.88
255.0×5.0×4.556.250.90
264.0×4.5×4.540.500.91
272.0×2.0×2.04.000.91
284.0×4.0×4.032.001.24
294.0×4.5×4.540.501.07
307.3×3.0×2.123.001.04
314.0×4.5×5.549.501.66
327.0×5.0×5.087.501.06
337.0×5.0×5.087.501.34
342.0×3.0×3.09.001.07
359.0×7.0×5.0157.501.09
363.0×2.0×2.06.000.95
3710.0×7.0×6.0210.001.07
383.0×4.5×4.530.381.18
393.0×3.0×3.013.501.37
404.0×4.0×5.544.001.06

[i] ADC, apparent diffusion coefficient.

The mean follow-up time was 12.9 months (range, 1–33 months). A total of 3 patients developed local recurrence and one patient developed lung metastasis. A total of 6 patients succumbed to hypopharyngeal carcinoma, and one mortality occurred as a result of accidental trauma.

Laryngostroboscopy in discriminating hypopharyngeal lesions

Of the 40 patients with hypopharyngeal SCC, 37 were diagnosed with hypopharyngeal carcinoma. Of the 15 patients with hypopharyngeal benign lesions, 3 were diagnosed with hypopharyngeal carcinoma. The sensitivity, specificity and accuracy were 92.5, 80.0 and 89.1%, respectively.

Conventional MRI, DWI, and ADC values: The diagnostic value of conventional MRI in hypopharyngeal lesions

A total of 10/40 hypopharyngeal SCCs (25.0%) were hyperintense on the T1-weighted image, 17 (42.5%) were isointense, 11 (27.5%) were hypointense and 2 (5.0%) gave heterogeneous signals. On the T2-weighted images, 38 (95.0%) were hyperintense, one (2.5%) was isointense and one (2.5%) gave a heterogeneous signal. In gadopentetic acid contrast-enhanced T1-weighted MRI, 15 (37.5%) exhibited heterogeneous enhancement, 24 (60.0%) were strongly enhanced and 1 (2.5%) was slightly enhanced. A total of 39/40 pathologically proven hypopharyngeal SCCs were diagnosed as hypopharyngeal carcinoma according to these observations (Table III; sensitivity, 97.5%).

Table III.

Conventional MRI observations in 40 hypopharyngeal lesions.

Table III.

Conventional MRI observations in 40 hypopharyngeal lesions.

SequenceSignalPatients (%)
T1W
Hyperintense10 (25.0)
Isointense17 (42.5)
Hypointense11 (27.5)
Heterogeneous2 (5.0)
T2W
Hyperintense38 (95.0)
Isointense1 (2.5)
Heterogeneous1 (2.5)
Contrast-enhanced T1W
Heterogeneous enhancement15 (37.5)
Strong enhancement24 (60.0)
Slight enhancement1 (2.5)

[i] T1W, T1-weighted.

In the T1-weighted images of 15 benign hypopharyngeal lesions, 3 (20.0%) exhibited no abnormal signal, 7 (46.7%) were hypointense, 4 (26.7%) were hyperintense and 1 (6.6%) was isointense. In the T2-weighted images, 14 (93.3%) were hyperintense and 1 (6.7%) exhibited no abnormal signal. In the contrast-enhanced T1-weighted MR images, 12 (80.0%) were strongly enhanced and three (20.0%) exhibited no enhancement. A total of 5/15 pathologically proven benign hypopharyngeal lesions were diagnosed as hypopharyngeal carcinoma. The specificity and accuracy were 66.7 and 89.1%, respectively.

DWI and ADC values

All 40 hypopharyngeal SCCs exhibited a high signal in DWI (Fig. 1). The mean ADC value was (1.03±0.0328)×10−3 mm2/sec. The ADCs of all patients who succumbed to mortality were below the mean ADC value. The tumor size (diameter and volume) was not significantly correlated with the tumor ADC value (P=0.996 and P=0.900, respectively). A total of 10/15 benign hypopharyngeal lesions (66.7%) exhibited high signals in DWI (Fig. 2). The mean ADC value (b=1,000 sec/mm2) was (1.53±0.106)×10−3 mm2/sec. The ADC values of hypopharyngeal SCCs were significantly lower than those of benign lesions (P<0.001; Fig. 3). ROC analysis revealed that the AUC was 0.921, while the optimal threshold for the ADC cut-off point was 1.075×10−3 mm2/sec, resulting in a sensitivity of 100% and a specificity of 75% (Fig. 4).

The role of DWI and ADC values in identifying metastatic lymph nodes in hypopharyngeal SCCs

The agreed ADC values in lesions on metastatic cervical lymph nodes and reactive cervical lymph nodes were 0.89×10−3 mm2/sec and 0.91×10−3 mm2/sec, respectively. Cervical lymph nodes were detected in 38/40 (95.0%) hypopharyngeal SCCs (Fig. 5). A total of 25 nodes were proven to be histologically malignant and 13 were benign. The mean ADC value of metastatic nodes was (0.918±0.0538)×10−3 mm2/sec, significantly lower than the mean value of the benign nodes [1.25±0.115)×10−3 mm2/sec; t=3.027; P=0.005). ROC curve analysis revealed that an optimal threshold value of 1.075×10−3 mm2/sec was suggested as the cut-off point, which results in 69.2% sensitivity and 84.0% specificity; the AUC was 0.778 with a confidence interval of 0.619–0.938 (P=0.005; Fig. 6).

ADC values, T stage and histological grade

The mean ADC value of early stage (T1+T2) hypopharyngeal SCCs was (0.998±0.0367)×10−3 mm2/sec. The mean ADC value of advanced stage (T3+T4) hypopharyngeal SCCs was (1.04±0.0412)×10−3 mm2/sec. However, this difference was not statistically significant (P>0.05). The mean ADC values of cases that were well differentiated, moderately differentiated, and poorly differentiated were (0.955±0.0590)×10−3 mm2/sec, (1.01±0.0337)×10−3 mm2/sec and (1.08±0.0686)×10−3 mm2/sec, respectively. However, these differences were not statistically significant (P>0.05).

Prognosis and ADC values

Cases were divided into two groups according to the mean ADC values of hypopharyngeal SCCs [≤(1.03±0.0328)×10−3 mm2/sec vs. >(1.03±0.0328)×10−3 mm2/sec). The 2-year overall survival rates of the groups were 55.6 and 100.0%, respectively, a statistically significant difference (Fig. 7; χ2=5.073; P<0.02). According to univariate analysis, other clinical parameters including age, sex, site of tumor, T stage, N stage and distant metastasis were not significant prognostic factors for survivalin hypopharyngeal carcinoma (P>0.05). However, recurrence and treatment modalities were prognostic factors for survival in hypopharyngeal carcinoma (P=0.016 and P<0.001, respectively). Patients who received surgical treatment in addition to postoperative CCR exhibited a better survival rate than those who received these treatment modalities alone. However, multivariate analysis indicated that recurrence was the only independent risk factor for survival in hypopharyngeal carcinoma (P<0.05).

Discussion

DWI has been widely used in the diagnosis, differential diagnosis and evaluation of cancer differentiation, clinical stage, outcome, recurrence and metastasis (914). Head and neck cancer occurs at multiple sites, including the oral cavity, oropharynx and larynx (9,10). In our previous study, ADC values were revealed to be lower in patients with T1 and T2 laryngeal carcinoma [mean, (1.195±0.32)×10−3 mm2/sec] than in those with laryngeal precancerous lesions [mean,(1.780±0.32)×10−3 mm2/sec; P<0.001] (12). ROC analysis revealed that the optimum threshold for the ADC was 1.455×10−3 mm2/sec, which may aid in distinguishing laryngeal carcinomas from laryngeal precancerous lesions (12). The present study continued to investigate the value of DWI in the diagnosis of hypopharyngeal carcinoma and in predicting its prognosis.

The results of the present study revealed that all 40 hypopharyngeal SCCs exhibited a high signal intensity in DWI. Furthermore, the mean ADC value of hypopharyngeal SCCs was lower than that of benign lesions (P<0.001).

These observations were similar to those from our previous study on early laryngeal carcinoma (12) and to those of other previous studies on head and neck carcinomas (4,10,15). Li et al (15) revealed that the mean ADC value of malignant lesions of the tongue [(1.08±0.16)×10−3 mm2/sec] was lower than that of benign lesions [(1.68±0.33)×10−3 mm2/sec] and cystic lesions [(2.21±0.35)×10−3 mm2/sec; P<0.001]. ROC analysis revealed that the AUC was 0.963 and the optimal threshold for the ADC cut-off point was 1.31×10−3 mm2/sec for predicting malignancy (15). A meta-analysis investigating DWI as a tool for differentiating malignancy from benign thyroid nodules undertaken by Wu et al (9) revealed that DWI sensitivity was 0.91 (95% CI, 0.86–0.94), specificity was 0.92 (95% CI, 0.84–0.97), and ROC curves demonstrated that AUC was 0.94 (95% CI, 0.92–0.96), indicating a high level of overall accuracy. A systemic review by Driessen et al (10) demonstrated that the accuracy range of DWI was 66–86% in the detection of primary head and neck squamous cell carcinoma (HNSCC). The mean of the ADC values in malignant lesions was significantly lower than that in benign lesions (4). This may be due to increased cell density, which restricts diffusion thereby decreasing ADC values in malignant lesions (4,6). Driessen et al (10) investigated the association between the ADC values of laryngeal and hypopharyngeal carcinomas and histopathological observations. A significant inverse correlation was observed between ADC values and cell density, nuclear area and the nuclear-cytoplasmic ratio, and a positive correlation was observed between ADC values and percentage area of the stroma (10). However, there is no standard ADC value that may be used as an optimal threshold for differentiating malignant lesions from benign lesions in the head and neck region (4,6,10,12). The wide variation in ADC thresholds may be due to multiple factors, including different b-values, field strengths, pathological types and delineation methods (4,6).

The present study revealed that ADC values were not correlated with tumor size. This observation was similar to that of McVeigh et al (16), who observed no correlation between ADC values and tumor volumes in cervical cancer. However, Husby et al (17) observed that ADC values were negatively correlated with tumor volume in endometrial carcinomas, suggesting that tumor volume reflects tumor progression and prognosis in endometrial carcinoma. The difference in the aforementioned results may be due to the various measurement methods used and the different b-values.

Another important feature of DWI is that ADC values may aid in detecting metastatic lymph nodes in patients with HNSCC (3,4,18,19). In the present study, 25 cervical lymph nodes were proven to be histologically malignant and 13 nodes were benign. The mean ADC value of metastatic nodes was significantly lower than that of benign nodes (P=0.005). ROC curve analysis revealed that an optimal threshold value of 1.075×10−3 mm2/sec was recommended as the cut-off point, resulting in 69.2% sensitivity and 84.0% specificity; the AUC was 0.778 (95% CI, 0.619–0.938; P=0.005). Additionally, Pekçevik et al (18) analyzed 33 patients with 53 metastatic lymph nodes of HNSCC. The mean ADC values for nodal metastases of nasopharyngeal carcinomas were significantly lower than those for nodal metastases of laryngeal carcinomas. Zhong et al (3) observed that 48 nodes were proven to be histologically malignant in 30 patients with HNSCC and 17 nodes were benign. The mean ADC value of the metastatic nodes (0.849×10−3 mm2/sec) was significantly lower than that of the benign nodes (1.443×10−3 mm2/sec; P<0.05). ROC curve analysis revealed that the AUC was 0.83 and the optimal threshold value was 0.960×10−3 mm2/sec, resulting in 89.58% sensitivity, 76.47% specificity and 86.15% accuracy. The aforementioned study also revealed that DWI with ADC value measurements may be more accurate than CT perfusion for the preoperative diagnosis of cervical lymph node metastases in patients with HNSCC (3). In oral squamous cell carcinoma (OSCC), 21 nodes were proven to be histologically malignant in 25 patients with OSCC and 30 nodes were reactive (18). The mean ADC value of the metastatic nodes [(0.702±0.197)×10−3 mm2/sec] was lower than that of the benign nodes [(1.037±0.149)×10−3 mm2/sec; P<0.05). ROC curve analysis revealed that the AUC was 0.887 and the optimal threshold value was 0.887×10−3 mm2/sec, resulting in 93.33% sensitivity, 80.95% specificity and 88.20% accuracy (18). However, Lim et al (20) revealed that the mean ADC does not discriminate benign from metastatic cervical lymph nodes in patients with HNSCC and non-necrotic, small lymph nodes. The aforementioned study also suggested that metastatic small foci in lymph nodes did not create sufficient architectural change to affect ADC values. However, the patients included in the study were examined using different MRI scanners (1.5-T, 3-T) (20). Sumi et al (21) observed the opposite results to those of the present study; higher ADC values in metastatic nodes than in benign lymphadenopathy (21). This discrepancy may be due to the number of necrotic regions within the metastatic nodes (21). Taken together, these data suggest that further large-scale studies focused on discriminating benign from metastatic cervical lymph nodes using ADC values are required.

In the present study, univariate analysis revealed that the mean ADC value was associated with the prognosis of patients with hypopharyngeal carcinoma. However, no significant correlation was observed between the mean ADC value and the prognosis of patients with hypopharyngeal carcinoma according to multivariate analysis, and the only independent risk factor for survival was recurrence. Similarly, in other types of cancer, Zhang et al (14) revealed that high ADC values were a good prognostic indicator in 541 patients with nasopharyngeal carcinoma (14). Hatakenaka et al (22) revealed found that ADC values were an independent prognostic indicator in cases of HNSCC treated with radiotherapy. Yoshida et al (23) also revealed that low ADC values (<1.10×10−3 mm2/sec) were significantly associated with shorter cancer-specific survival of patients with upper urinary tract cancer. However, certain studies have reported that ADC values were not associated with survival of patients with HNSCC who were treated with radiotherapy (24,25). The reason for these contradictory results remains unclear. Hatakenaka et al (22) assessed possible reasons and proposed that ADC values calculated from different b-values may have an effect. For example, ADC values of 0 and 1,000 sec/mm2 are not significantly associated with overall survival in patients with HNSCC treated with radiotherapy. In the aforementioned study, patients with a higher ADC value (0–200 sec/mm2) exhibited a relatively good prognosis, while those with a lower ADC value (300–1,000 sec/mm2) exhibited a favorable prognosis (22). It was suggested that the spatial distribution of photons in cancer cells is heterogeneous; certain cancer cells with low ADC values were critically damaged following radiotherapy, while other adjacent cells were not (22). These critically damaged cells prevented chemical substances from diffusing to adjacent cancer cells and resulted in damage to the adjacent cancer cells and radio sensitivity. There may also be a converse effect in those cancer cells with high ADC values (22). The present study revealed that ADC values were not associated with T stage or histological grade, observations with were similar to those of previous reports (23,26). Recently, it has been suggested that a histogram of ADC values may better reflect ADC heterogeneity. Certain studies have demonstrated that ADC histograms may be associated with T stage and prognosis of certain types of solid cancer (2729). Therefore, future studies should investigate the association between ADC histograms and prognosis in HNSCC.

The present study has certain limitations. To begin with, the present study incorporated a small sample size with relatively short follow-up periods. Additionally, only advanced-stage hypopharyngeal carcinoma was investigated. Furthermore, multiple b-values were not used to calculate ADCs. Finally, the present study was retrospective in nature, resulting in unavoidable bias. Therefore, large-scale prospective multi-center studies are required for further study.

In conclusion, ADC values may discriminate hypopharyngeal carcinomas from benign lesions and may also discriminate metastatic lymph nodes of hypopharyngeal SCCs from reactive cervical lymph nodes. Furthermore, mean ADC values may be a useful prognostic factor in univariate analysis.

Acknowledgements

The present study was supported by the National Natural Science Foundation of China (grant no. 81372903) and the Science and Technology Department of Zhejiang Province, China (grant no. 2016C33G2010117).

Competing interests

The authors declare that they have no competing interests.

References

1 

Kim JW, Kim MS, Kim SH, Kim JH, Lee CG, Kim GE and Keum KC: Definitive chemoradiotherapy versus surgery followed by adjuvant radiotherapy in resectable stage III/IV hypopharyngeal cancer. Cancer Res Treat. 48:45–53. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Vandersteen C, Benezery K, Chamorey E, Ettaiche M, Dassonville O, Poissonnet G, Riss JC, Pierre CS, Hannoun-Lévi JM, Chand Me, et al: Contemporary therapeutic management of locally advanced hypopharyngeal cancer: oncologic and functional outcomes-a report on 100 cases. Acta Otolaryngol. 135:193–200. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Zhong J, Lu Z, Xu L, Dong L, Qiao H, Hua R, Gong Y, Liu Z, Hao C, Liu X, et al: The diagnostic value of cervical lymph node metastasis in head and neck squamous carcinoma by using diffusion-weighted magnetic resonance imaging and computed tomography perfusion. Biomed Res Int. 2014:2608592014. View Article : Google Scholar : PubMed/NCBI

4 

Driessen JP, van Kempen PM, van der Heijden GJ, Philippens ME, Pameijer FA, Stegeman I, Terhaard CH, Janssen LM and Grolman W: Diffusion-weighted imaging in head and neck squamous cell carcinomas: A systematic review. Head Neck. 37:440–448. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Sun Y, Tong T, Cai S, Bi R, Xin C and Gu Y: Apparent diffusion coefficient (ADC) value: A potential imaging biomarker that reflects the biological features of rectal cancer. PLoS One. 9:e1093712014. View Article : Google Scholar : PubMed/NCBI

6 

Payne KF, Haq J, Brown J and Connor S: The role of diffusion-weighted magnetic resonance imaging in the diagnosis, lymph node staging and assessment of treatment response of head and neck cancer. Int J Oral Maxillofac Surg. 44:1–7. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Chawla S, Kim S, Wang S and Poptani H: Diffusion-weighted imaging in head and neck cancers. Future Oncol. 5:959–975. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Thoeny HC, De Keyzer F and King AD: Diffusion-weighted MR imaging in the head and neck. Radiology. 263:19–32. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Wu LM, Xu JR, Liu MJ, Zhang XF, Hua J, Zheng J and Hu JN: Value of magnetic resonance imaging for nodal staging in patients with head and neck squamous cell carcinoma: A meta-analysis. Acad Radiol. 19:331–340. 2012. View Article : Google Scholar : PubMed/NCBI

10 

Driessen JP, Caldas-Magalhaes J, Janssen LM, Pameijer FA, Kooij N, Terhaard CH, Grolman W and Philippens ME: Diffusion-weighted MR imaging in laryngeal and hypopharyngeal carcinoma: Association between apparent diffusion coefficient and histologic findings. Radiology. 272:456–463. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Lee CC, Ho HC, Su YC, Yu CH and Yang CC: Modified tumor classification with inclusion of tumor characteristics improves discrimination and prediction accuracy in oral and hypopharyngeal cancer patients who underwent surgery. Medicine (Baltimore). 94:e11142015. View Article : Google Scholar : PubMed/NCBI

12 

Shang DS, Ruan LX, Zhou SH, Bao YY, Cheng KJ and Wang QY: Differentiating laryngeal carcinomas from precursor lesions by diffusion-weighted magnetic resonance imaging at 3.0 T: A preliminary study. PLoS One. 8:e686222013. View Article : Google Scholar : PubMed/NCBI

13 

Hwang I, Choi SH, Kim YJ, Kim KG, Lee AL, Yun TJ, Kim JH and Sohn CH: Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: Application of high b-value diffusion-weighted imaging. AJNR Am J Neuroradiol. 34:2343–2348. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Zhang Y, Liu X, Zhang Y, Li WF, Chen L, Mao YP, Shen JX, Zhang F, Peng H, Liu Q, et al: Prognostic value of the primary lesion apparent diffusion coefficient (ADC) in nasopharyngeal carcinoma: A retrospective study of 541 cases. Sci Rep. 5:122422015. View Article : Google Scholar : PubMed/NCBI

15 

Li S, Cheng J, Zhang Y and Zhang Z: Differentiation of benign and malignant lesions of the tongue by using diffusion-weighted MRI at 3.0 T. Dentomaxillofac Radiol. 44:201403252015. View Article : Google Scholar : PubMed/NCBI

16 

McVeigh PZ, Syed AM, Milosevic M, Fyles A and Haider MA: Diffusion-weighted MRI in cervical cancer. Eur Radiol. 18:1058–1064. 2008. View Article : Google Scholar : PubMed/NCBI

17 

Husby JA, Salvesen ØO, Magnussen IJ, Trovik J, Bjørge L, Salvesen HB and Haldorsen IS: Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas. Clin Radiol. 70:487–494. 2015. View Article : Google Scholar : PubMed/NCBI

18 

Pekçevik Y, Çukurova İ and Arslan İB: Apparent diffusion coefficient for discriminating metastatic lymph nodes in patients with squamous cell carcinoma of the head and neck. Diagn Interv Radiol. 21:397–402. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Si J, Huang S, Shi H, Liu Z, Hu Q, Wang G, Shen G and Zhang D: Usefulness of 3T diffusion-weighted MRI for discrimination of reactive and metastatic cervical lymph nodes in patients with oral squamous cell carcinoma: A pilot study. Dentomaxillofac Radiol. 43:201302022014. View Article : Google Scholar : PubMed/NCBI

20 

Lim HK, Lee JH, Baek HJ, Kim N, Lee H, Park JW, Kim SY, Cho KJ and Baek JH: Is diffusion-weighted MRI useful for differentiation of small non-necrotic cervical lymph nodes in patients with head and neck malignancies? Korean J Radiol. 15:810–816. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Sumi M, Sakihama N, Sumi T, Morikawa M, Uetani M, Kabasawa H, Shigeno K, Hayashi K, Takahashi H and Nakamura T: Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol. 24:1627–1634. 2003.PubMed/NCBI

22 

Hatakenaka M, Nakamura K, Yabuuchi H, Shioyama Y, Matsuo Y, Kamitani T, Yonezawa M, Yoshiura T, Nakashima T, Mori M and Honda H: Apparent diffusion coefficient is a prognostic factor of head and neck squamous cell carcinoma treated with radiotherapy. Jpn J Radiol. 32:80–89. 2014. View Article : Google Scholar : PubMed/NCBI

23 

Yoshida S, Kobayashi S, Koga F, Ishioka J, Ishii C, Tanaka H, Nakanishi Y, Matsuoka Y, Numao N, Saito K, et al: Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: A preliminary report. Eur Radiol. 23:2206–2214. 2013. View Article : Google Scholar : PubMed/NCBI

24 

Galban CJ, Mukherji SK, Chenevert TL, Meyer CR, Hamstra DA, Bland PH, Johnson TD, Moffat BA, Rehemtulla A, Eisbruch A and Ross BD: A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol. 2:184–190. 2009. View Article : Google Scholar : PubMed/NCBI

25 

Vandecaveye V, Dirix P, De Keyzer F, Op de Beeck K, Vander Poorten V, Hauben E, Lambrecht M, Nuyts S and Hermans R: Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 82:1098–1107. 2012. View Article : Google Scholar : PubMed/NCBI

26 

Kamitani T, Matsuo Y, Yabuuchi H, Fujita N, Nagao M, Jinnouchi M, Yonezawa M, Yamasaki Y, Tokunaga E, Kubo M, et al: Correlations between apparent diffusion coefficient values and prognostic factors of breast cancer. Magn Reson Med Sci. 12:193–199. 2013. View Article : Google Scholar : PubMed/NCBI

27 

Xue H, Ren C, Yang J, Sun Z, Li S, Jin Z, Shen K and Zhou W: Histogram analysis of apparent diffusion coefficient for the assessment of local aggressiveness of cervical cancer. Arch Gynecol Obstet. 290:341–348. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Downey K, Riches SF, Morgan VA, Giles SL, Attygalle AD, Ind TE, Barton DP, Shepherd JH and De Souza NM: Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: Quantitative histogram analysis of diffusion-weighted MR images. AJR Am J Roentgenol. 200:314–320. 2013. View Article : Google Scholar : PubMed/NCBI

29 

Ahn SJ, Choi SH, Kim YJ, Kim KG, Sohn CH, Han MH, Chang KH and Min HS: Histogram analysis of apparent diffusion coefficient map of standard and high B-value diffusion MR imaging in head and neck squamous cell carcinoma: A correlation study with histological grade. Acad Radiol. 19:1233–1240. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April-2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang SC, Zhou SH, Shang DS, Bao YY, Ruan LX and Wu TT: The diagnostic role of diffusion-weighted magnetic resonance imaging in hypopharyngeal carcinoma. Oncol Lett 15: 5533-5544, 2018
APA
Zhang, S., Zhou, S., Shang, D., Bao, Y., Ruan, L., & Wu, T. (2018). The diagnostic role of diffusion-weighted magnetic resonance imaging in hypopharyngeal carcinoma. Oncology Letters, 15, 5533-5544. https://doi.org/10.3892/ol.2018.8053
MLA
Zhang, S., Zhou, S., Shang, D., Bao, Y., Ruan, L., Wu, T."The diagnostic role of diffusion-weighted magnetic resonance imaging in hypopharyngeal carcinoma". Oncology Letters 15.4 (2018): 5533-5544.
Chicago
Zhang, S., Zhou, S., Shang, D., Bao, Y., Ruan, L., Wu, T."The diagnostic role of diffusion-weighted magnetic resonance imaging in hypopharyngeal carcinoma". Oncology Letters 15, no. 4 (2018): 5533-5544. https://doi.org/10.3892/ol.2018.8053